Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Bridging the Gender Gap: Inspiring Words from the Women Making Waves on Starship | Annie Handrick | | Starship Technologies | March 2023

    March 8, 2023

    AI apps like ChatGPT may finally kill the cover letter

    March 8, 2023

    Snow Crash author Neal Stephenson on the metaverse, making movies, climate fears

    March 6, 2023
    Facebook Twitter Instagram
    Trending
    • Bridging the Gender Gap: Inspiring Words from the Women Making Waves on Starship | Annie Handrick | | Starship Technologies | March 2023
    • AI apps like ChatGPT may finally kill the cover letter
    • Snow Crash author Neal Stephenson on the metaverse, making movies, climate fears
    • A new era of tech coverage at Vox
    • How generative AI from OpenAI and Google is transforming search — and maybe everything else
    • Is the US actually banning TikTok over China ties?
    • TikTok’s new screen time limit for kids has limits
    • Section 230: The Supreme Court considers two cases that may challenge it
    Facebook Twitter Instagram YouTube
    PayDay Loans All OnlinePayDay Loans All Online
    • Home
    • Earnings

      Stocks fall as disappointing iPhone sales lead to lower profits

      February 2, 2023

      Apple, Amazon, Google report earnings

      February 2, 2023

      Will Qorvo Post Second Quarter Earnings? (NASDAQ:QRVO)

      February 2, 2023

      Earnings for Apple, Amazon and Alphabet are coming. Here’s what the stock options market has to offer:

      February 2, 2023

      What To Expect From Google’s Parent Alphabet Today

      February 2, 2023
    • FTA

      Arrests and incidents reported on 2 February 2023

      February 2, 2023

      It makes economic sense to increase trade within Asia

      February 2, 2023

      Arrested and Booked 2/2/23 | Clay of the Day

      February 2, 2023

      Prison Logs Feb 3, 2023 | Crime

      February 2, 2023

      Ukraine expects adoption of priority action plan to strengthen implementation of FTA with EU in 2023-2024 – Shmyhal

      February 2, 2023
    • General

      Why General Motors stock rose nearly 6% today

      February 2, 2023

      Taiwan activates defenses in response to Chinese aggression. A leaked memo of a US general warns of armed conflict with China by 2025.

      February 2, 2023

      Israeli attorney general says Netanyahu cannot get involved in judicial overhaul

      February 2, 2023

      State general revenue increased $25 million in January to $807 million

      February 2, 2023

      Panoramic Ventures Hires Christy Johnson as General Partner and Chief Operating Officer

      February 2, 2023
    • Investing

      3 Dividend Aristocrats to Buy Now

      February 2, 2023

      Bottom in?Metaplatform surge after earnings

      February 2, 2023

      Why Amazon’s stock jumped 23% in January

      February 2, 2023

      Why Cloudflare’s stock skyrocketed on Thursday

      February 2, 2023

      Pre-listing Stocks: Meta Surprised Wall Street, But Investors Still Tech Skeptical

      February 2, 2023
    • Politics

      US reunites nearly 700 children taken from their parents under Trump

      February 2, 2023

      Federal Election Commission Raises Political Contribution Cap

      February 2, 2023

      Blinken Visited Beijing Under Pressure To Impose China Role In Deadly Fentanyl Deal

      February 2, 2023

      Potomac Phil Predict’s DC Weather and Political Climate – NBC4 Washington

      February 2, 2023

      Maeve Reston joins Post as national political reporter

      February 2, 2023
    • RWL

      Understanding the Mentoring Relationship Between Mentees, Peers, and Senior Mentors | BMC Medical Education

      January 31, 2023

      i am a personal trainer. Here’s why you need to exercise less to lose weight.

      January 29, 2023

      i am a personal trainer. Here’s why you need to exercise less to lose weight.

      January 29, 2023

      i am a personal trainer. Here’s why you need to exercise less to lose weight.

      January 29, 2023

      i am a personal trainer. Here’s why you need to exercise less to lose weight.

      January 29, 2023
    • Small Cap

      VanEck Vector Brazilian Small Cap ETF: Ideal Conditions (NASDAQ:EWZS)

      February 2, 2023

      Phillips Financial Management LLC invests $104,000 in the iShares MSCI EAFE Small Cap ETF (NASDAQ:SCZ)

      February 2, 2023

      Investors are interested in Lattice Semiconductor Corporation (LSCC) stock because:

      February 2, 2023

      Goldman Small Cap Research Publishes New Research Report on KwikClick, Inc.

      February 2, 2023

      Top 3 Small Caps Up Over 5% Today; Do You Own It?

      February 2, 2023
    PayDay Loans All OnlinePayDay Loans All Online
    Home » Two struggling stocks to replace in 2023 and one to avoid like the plague
    Investing

    Two struggling stocks to replace in 2023 and one to avoid like the plague

    paydayloansallonline_110na0By paydayloansallonline_110na0January 29, 2023No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Last year’s difficult markets meant many stocks struggled – even those with bright future prospects. That’s why you shouldn’t turn away thinking that all these players have problems. Instead, you should look at stocks individually. And if you do this, you’ll be more likely to spot big buy opportunities today, as well as identify stocks to avoid.

    Buying an opportunity means stocks that currently look very cheap given their potential future gains. Stocks to avoid are stocks that do not yet have a clear path to growth. There are many examples of both in the healthcare world. So let’s check out the two stocks he’s struggling to hand over right now and the one he should avoid like the plague.

    Stocks to buy: Teladoc Health

    Teladoc Health (TDOC 6.47%) It dropped 74% last year, and for one specific reason. The telemedicine giant reported a $2 billion non-cash goodwill impairment charge, both related to its acquisition of chronic disease specialist Livongo.

    Investors are eager to turn the company’s growing earnings into profitability. But after announcing the impairment claim, that goal seemed even further away.

    But in Q3, Teladoc gave us reason to be optimistic. The company reported no further impairment charges and its net loss narrowed. At the same time, Teladoc continues his double-digit growth in revenue and visits. The situation looks bright even for the whole year. The company recently raised its full-year earnings forecast.

    Teladoc is an industry leader with double-digit growth. And buying Livongo should pay off in the end. Nearly half of all Americans suffer from at least one chronic disease. All of this means that Teladoc, which is trading at its lowest ever multiple, looks like a steal for now.

    Stock to buy: Moderna

    Moderna (mRNA -2.01%) The stock has fallen in 2022, but has risen so far this year, and for good reason. The company provided positive news about the potential of the coronavirus vaccine market post-pandemic. Moderna has also advanced late-stage programs in its pipeline.

    Let’s take a quick look here. Moderna expects the post-pandemic vaccine market to grow from $12 billion to $24 billion. The company also talked about charging up to $130 for the vaccine. Up from about $25 today. So it’s clear that Moderna has the potential to generate continued blockbuster revenue from its annual coronavirus boosters – even if demand is much lower than it was early in the pandemic.

    At the same time, Moderna may launch additional products. The company aims to bring influenza and respiratory syncytial virus vaccines to market within the next few years. These represent a multi-billion dollar market.

    This biotechnology has a total of 48 programs in development across many therapeutic areas. Even a handful of successes can lead to big profits down the road. All this means that Moderna’s coming-of-age story is just beginning. And now it’s time to get on board.

    Stock to Avoid: Ocugen

    Ocugen (OCGN 5.83%) Stocks surged early in the pandemic on hopes that a coronavirus vaccine would hit the market. The company has the US and Canadian commercial rights to his Covaxin, which was developed by his Bharat Biotech in India. The problem is that these countries have not yet approved Covaxin. As such, Ocugen does not generate vaccine revenue.

    And even if the US and Canada approve covacine in the future, it will not be easy for latecomers to carve out market share in a post-pandemic world.

    But what about the rest of the pipeline? Ocugen has expanded its focus from gene therapy to treat eye diseases to include assets acquired as part of a reverse merger with Histogenics in 2019. That is NeoCart for knee cartilage lesion repair.

    In Histogenics, NeoCart did not meet its primary endpoint in a Phase 3 trial. However, other results were convincing. Therefore, NeoCart and Ocugen could be successful in the upcoming new Phase 3 trials. The eye disease candidate is still in the early stages of development.

    R&D costs are rising to support these programs. It more than doubled year-over-year in the third quarter. At the same time, Ocugen’s path to profitability is unclear. So at the moment, Ocugen is at the top of my “stocks to avoid” list.

    Adria Cimino has no positions in any of the mentioned stocks. The Motley Fool holds positions in and recommends Teladoc Health. The Motley Fool recommends Moderna stock. The Motley Fool’s U.S. headquarters has a disclosure policy.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    paydayloansallonline_110na0
    • Website

    Related Posts

    3 Dividend Aristocrats to Buy Now

    February 2, 2023

    Bottom in?Metaplatform surge after earnings

    February 2, 2023

    Why Amazon’s stock jumped 23% in January

    February 2, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Bridging the Gender Gap: Inspiring Words from the Women Making Waves on Starship | Annie Handrick | | Starship Technologies | March 2023

    March 8, 2023

    AI apps like ChatGPT may finally kill the cover letter

    March 8, 2023

    Snow Crash author Neal Stephenson on the metaverse, making movies, climate fears

    March 6, 2023

    A new era of tech coverage at Vox

    March 6, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    News

    Bridging the Gender Gap: Inspiring Words from the Women Making Waves on Starship | Annie Handrick | | Starship Technologies | March 2023

    By paydayloansallonline_110na0March 8, 20230

    Author: Lys VerthalIn honor of International Women’s Day today, we’ve compiled a list of powerful…

    AI apps like ChatGPT may finally kill the cover letter

    March 8, 2023

    Snow Crash author Neal Stephenson on the metaverse, making movies, climate fears

    March 6, 2023

    A new era of tech coverage at Vox

    March 6, 2023
    About Us

    This website provides information about FTA and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Our Picks

    Noise-Cancelling Headphones For a Superb Music Experience

    January 15, 2020

    Harry Potter: 10 Things Dursleys That Make No Sense

    January 15, 2020

    Dubai-Based Yacht Company is Offering Socially-Distanced Luxury

    January 15, 2020

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Facebook Twitter Instagram Pinterest
    • Home
    • DMCA
    • Privacy Policy
    • Contact us
    © 2023 paydayloansallonline. Designed by paydayloansallonline.

    Type above and press Enter to search. Press Esc to cancel.